Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5–26. https://doi.org/10.3322/canjclin.53.1.5

Article  PubMed  Google Scholar 

Griffiths CT. Surgical resection of Tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr. 1975;42:101–4.

PubMed  CAS  Google Scholar 

Winter WE 3rd, Maxwell GL, Tian C, Carlson JW, Ozols RF, Rose PG, et al. Prognostic factors for stage III epithelial Ovarian cancer: a gynecologic Oncology Group Study. J Clin Oncol. 2007;25:3621–7. https://doi.org/10.1200/JCO.2006.10.2517

Article  PubMed  Google Scholar 

Johnson RL, Laios A, Jackson D, Nugent D, Orsi NM, Theophilou G, et al. The uncertain benefit of adjuvant chemotherapy in advanced low-grade serous Ovarian cancer and the pivotal role of surgical cytoreduction. J Clin Med. 2021;10:5927. https://doi.org/10.3390/jcm10245927

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chi DS, Eisenhauer EL, Lang J, Huh J, Abu-Rustum NR, Sonoda Y, et al. What is the optimal goal of primary cytoreductive Surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol. 2006;103:559–64. https://doi.org/10.1016/j.ygyno.2006.03.051

Article  PubMed  CAS  Google Scholar 

Chi DS, Eisenhauer EL, Zivanovic O, Abu-Rustum NR, Levine DA, Guile MW, et al. Improved progression-free and overall survival in advanced Ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol. 2009;114:26–31. https://doi.org/10.1016/j.ygyno.2009.03.018

Article  PubMed  Google Scholar 

du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial Ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’Investigateurs Nationaux Pour Les Etudes des Cancers de l’Ovaire (GINECO). Cancer. 2009;115:1234–44. https://doi.org/10.1002/cncr.24149

Article  PubMed  CAS  Google Scholar 

Lawton FG, Redman CW, Luesley DM, Chan KK, Blackledge G. Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking Surgery in advanced, unresected epithelial Ovarian cancer. Obstet Gynecol. 1989;73:61–5.

PubMed  CAS  Google Scholar 

Bristow RE, Chi DS. Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced Ovarian cancer: a meta-analysis. Gynecol Oncol. 2006;103:1070–6. https://doi.org/10.1016/j.ygyno.2006.06.025

Article  PubMed  CAS  Google Scholar 

Coleridge SL, Bryant A, Kehoe S, Morrison J. Chemotherapy versus Surgery for initial treatment in advanced ovarian epithelial cancer. Cochrane Database Syst Rev. 2019;10:CD005343. https://doi.org/10.1002/14651858.CD005343.pub5

Article  Google Scholar 

Chi DS, Franklin CC, Levine DA, Akserol F, Sabbatini P, Jarnagin WR, et al. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Gynecol Oncol. 2004;94:650–4. https://doi.org/10.1016/j.ygyno.2004.01.029

Article  PubMed  Google Scholar 

Eisenkop SM, Spirtos NM, Friedman RL, Lin WC, Pisani AL, Perticucci S. Relative influences of Tumor volume before Surgery and the cytoreductive outcome on survival for patients with advanced Ovarian cancer: a prospective study. Gynecol Oncol. 2003;90:390–6. https://doi.org/10.1016/s0090-8258(03)00278-6

Article  PubMed  Google Scholar 

Barton DP, Adib T, Butler J. Surgical practice of UK gynaecological oncologists in the treatment of primary advanced epithelial Ovarian cancer (PAEOC): a questionnaire survey. Gynecol Oncol. 2013;131:347–51. https://doi.org/10.1016/j.ygyno.2013.08.007

Article  PubMed  CAS  Google Scholar 

Fotopoulou C, Concin N, Planchamp F, Chiva L, Cina A, Ergonol O, et al. Quality indicators for advanced Ovarian cancer Surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update. Int J Gynecol Cancer. 2020;30:436–40. https://doi.org/10.1136/ijgc-2020-001248

Article  PubMed  Google Scholar 

Laios A, Katsenou A, Tan YS, Johnson R, Otify M, Kaufmann A, et al. Feature selection is critical for 2-year prognosis in advanced stage high grade serous Ovarian cancer by using machine learning. Cancer Control. 2021;28:10732748211044678. https://doi.org/10.1177/10732748211044678

Article  PubMed  PubMed Central  Google Scholar 

Dindo D, Demartines N, Clavien PA. Classification of Surgical Complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13. https://doi.org/10.1097/01.sla.0000133083.54934.ae

Article  PubMed  PubMed Central  Google Scholar 

Mutch DG, Prat J. FIGO staging for ovarian, fallopian tube and peritoneal cancer. Gynecol Oncol. 2014;133:401–4. https://doi.org/10.1016/j.ygyno.2014.04.013

Article  PubMed  Google Scholar 

Newsham AC, Johnston C, Hall G, Leahy MG, Smith MB, Vikram A, et al. Development of an advanced database for clinical trials integrated with an electronic patient record system. Comput Biol Med. 2011;41:575–86. https://doi.org/10.1016/j.compbiomed.2011.04.014

Article  PubMed  Google Scholar 

Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–55.

Article  PubMed  CAS  Google Scholar 

Nelson G, Bakkum-Gamez J, Kalogera E, Glaser G, Altman A, Meyer LA, et al. Guidelines for perioperative care in gynecologic/oncology: enhanced recovery after Surgery (ERAS) society recommendations-2019 update. Int J Gynecol Cancer. 2019;29:651–68. https://doi.org/10.1136/ijgc-2019-000356

Article  PubMed  Google Scholar 

Moran J, Wilson F, Guinan E, McCormick P, Hussey J, Moriarty J. Role of cardiopulmonary exercise testing as a risk assessment method in patients undergoing intra-abdominal Surgery: a systematic review. Br J Anaesth. 2016;116:177–91. https://doi.org/10.1093/bja/aev454

Article  PubMed  CAS  Google Scholar 

Laios A, De Oliveira Silva RV, Dantas De Freitas DL, Tan YS, Saalmink G, Zubayraeva A, et al. Machine learning-based risk prediction of critical care unit admission for Advanced Stage High Grade Serous Ovarian Cancer patients undergoing cytoreductive Surgery: the Leeds-Natal score. J Clin Med. 2022;11:87. https://doi.org/10.3390/jcm11010087

Article  Google Scholar 

Höckel M. Laterally extended endopelvic resection (LEER)--principles and practice. Gynecol Oncol. 2008;111:13–7. https://doi.org/10.1016/j.ygyno.2008.07.022

Article  Google Scholar 

Lopez MJ, Luna-Pérez P. Composite pelvic exenteration: is it worthwhile? Ann Surg Oncol. 2004;11:27–33. https://doi.org/10.1007/BF02524342

Article  PubMed  Google Scholar 

Fotopoulou C, Planchamp F, Aytulu T, Chiva L, Cina A, Ergönül Ö, et al. European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced Ovarian cancer patients undergoing debulking Surgery. Int J Gynecol Cancer. 2021;31:1199–206. https://doi.org/10.1136/ijgc-2021-002951

Article  PubMed  Google Scholar 

Laios A, Kalampokis E, Johnson R, Thangavelu A, Tarabanis C, Nugent D, et al. Explainable Artificial Intelligence for Prediction of Complete Surgical Cytoreduction in Advanced-Stage Epithelial Ovarian Cancer. J Pers Med. 2022;12:607. https://doi.org/10.3390/jpm12040607

Article  PubMed  PubMed Central  Google Scholar 

Sugarbaker PH. Cytoreductive Surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol. 2001;27:239–43. https://doi.org/10.1053/ejso.2000.1038

Article  PubMed  CAS  Google Scholar 

Aletti GD, Santillan A, Eisenhauer EL, Hu J, Aletti G, Podratz KC, et al. A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for Ovarian cancer using a risk-adjusted model. Gynecol Oncol. 2007;107:99–106. https://doi.org/10.1016/j.ygyno.2007.05.032

Article  PubMed  Google Scholar 

Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359–74. https://doi.org/10.1007/978-1-4613-1247-5_23

Article  PubMed  CAS  Google Scholar 

Hamilton CA, Miller A, Miller C, Krivak TC, Farley JH, Chernofsky MR, et al. The impact of Disease distribution on survival in patients with stage III epithelial Ovarian cancer cytoreduced to microscopic residual: a Gynecologic Oncology Group study. Gynecol Oncol. 2011;122:521–6. https://doi.org/10.1016/j.ygyno.2011.04.041

Article  PubMed  PubMed Central  Google Scholar 

Fagotti A, Ferrandina MG, Vizzielli G, Pasciuto T, Fanfani F, Gallotta V, et al. Randomized trial of primary debulking Surgery versus neoadjuvant chemotherapy for advanced epithelial Ovarian cancer (SCORPION-NCT01461850). Int J Gynecol Cancer. 2020;30:1657–64. https://doi.org/10.1136/ijgc-2020-001640

Article  PubMed  Google Scholar 

Soleymani Majd H, Ferrari F, Manek S, Gubbala K, Campanile RG, Hardern K, et al. Diaphragmatic peritonectomy vs. full thickness resection with pleurectomy during visceral-peritoneal debulking (VPD) in 100 consecutive patients with stage IIIC-IV Ovarian cancer: a surgical-histological analysis. Gynecol Oncol. 2016;140:430–5. https://doi.org/10.1016/j.ygyno.2015.12.004

Article  PubMed  Google Scholar 

Laios A, Kalampokis E, Johnson R, Munot S, Thangavelu A, Hutson R, et al. Development of a novel intra-operative score to record Diseases’ anatomic fingerprints (ANAFI score) for the prediction of complete cytoreduction in Advanced-Stage Ovarian Cancer by using machine learning and explainable Artificial Intelligence. Cancers (Basel). 2023;15:966. https://doi.org/10.3390/cancers15030966

Article  PubMed  Google Scholar 

Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Relationship among surgical complexity, short-term morbidity, and overall survival in primary Surgery for advanced Ovarian cancer. Am J Obstet Gynecol. 2007;197:676e1–7. https://doi.org/10.1016/j.ajog.2007.10.495

Article